Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Long-acting insulin is safer, more effective for patients with Type 1 diabetes

01.10.2014

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with Type 1 diabetes, according to new research published in the BMJ.

Researchers looked at once-daily and twice-daily doses of both long- and intermediate-acting insulin, ranking their effectiveness, safety and cost-effectiveness.


"In patients with Type 1 diabetes, we found that long-acting insulin is superior to intermediate-acting insulin when it came to controlling blood sugar, preventing weight gain and treating severe hypoglycemia," said Dr. Andrea Tricco, the lead author of the paper and a scientist in the Li Ka Shing Knowledge Institute of St. Michael's Hospital.

Credit: Antonia Giroux Photography

"In patients with Type 1 diabetes, we found that long-acting insulin is superior to intermediate-acting insulin when it came to controlling blood sugar, preventing weight gain and treating severe hypoglycemia," said Dr. Andrea Tricco, the lead author of the paper and a scientist in the Li Ka Shing Knowledge Institute of St. Michael's Hospital.

Using data from 39 studies, Dr. Tricco and her colleagues compared two long-acting forms of insulin – glargine and detemir – against intermediate-acting forms, such as such as Neutral Protamine Hagedorn.

Long-acting insulin takes about one hour after ingesting to begin lowering blood sugar and lasts up to 26 hours. Intermediate-acting insulin takes between one and three hours to begin lowering blood sugar and can last up to 16 hours.

Compared to intermediate-acting NPH, long-acting insulin significantly improved Hemoglobin A1C levels, a measure of effective blood sugar control over time.

"Those taking intermediate-acting insulin were more likely to gain weight," said Dr. Tricco, who has a PhD in population health and is also an assistant professor in the University of Toronto's Dalla Lana School of Public Health. "They gained an average of four to six pounds more than the participants who took most long-acting insulin doses."

Severe hypoglycemia, when someone has extremely low blood sugar, is a medical emergency where the individual is unable to treat themselves. When someone is severely hypoglycemic, they need someone else to provide them with sugar quickly through food or via intravenous fluids.

The researchers found that people with Type 1 diabetes were 38 per cent less likely to experience severe hypoglycemia, on average.

Dr. Tricco also looked at the cost-effectiveness between the two types of insulin.

Of the 32 studies included in the review, there were 22 analyses evaluating the economic benefits of long- and intermediate-acting insulin. Seventy-seven per cent of those economic analyses found that long-acting insulin was more expensive but also more effective than intermediate-acting insulin. Twenty-three per cent found long-acting insulin more cost-effective.

"With this information, patients and their doctors should tailor their choice of insulin according to preference, cost and accessibility," said Dr. Tricco.

###

This research was funded by the Drug Safety and Effectiveness Network of Canadian Institutes of Health Research.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contacts
For more information, or to arrange an interview, please contact:
Geoff Koehler
Adviser, Media Relations
St. Michael's Hospital
416-864-6060 ext. 6537
koehlerg@smh.ca

Geoff Koehler | Eurek Alert!
Further information:
http://www.stmichaelshospital.com/

Further reports about: Health analyses blood sugar blood sugar control hypoglycemia types of insulin

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>